The global c-reactive protein testing market size is expected to reach USD 2,158.62 million by 2029 according to this new study. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022-2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.
![C-Reactive Protein Testing Market]( "C-Reactive Protein Testing Market")
Increasing heart-related diseases due to the increasing geriatric population, obesity, and others are expected to increase the demand for the industry over the forecast period. Additionally, rising awareness for preventing and treating cardiovascular diseases, along with increasing investments for novel techniques, are expected to propel the industry over the forecast period.
Furthermore, the ongoing COVID-19 pandemic has increased the demand for innovative diagnosis with rapid results, has increased the demand for point-of-care testing, which in turn has benefited the industry and is expected to increase over the forecast period.
North America is expected to dominate the global market over the forecast period due to the presence of private and government reimbursement structures for these tests. For instance, in addition to payment for generic inflammatory screening, BlueCross BlueShield of North Carolina covers C-reactive protein tests in the detection of inflamed illnesses.
Some of the major players in the market include Abbott, Aidian, Abaxis, Inc, BODITECH MED, Inc, F. Hoffmann-La Roche Ltd., Danaher, Thermo Fisher Scientific, Inc, Getein Biotech, Inc, Laboratory Corporation of America Holdings, HORIBA, Ltd., Merck KGaA, Quest Diagnostics, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Siemens Healthineers AG, Roche Ltd., and Zoetis.
Furthermore, the ongoing COVID-19 pandemic has increased the demand for innovative diagnosis with rapid results, has increased the demand for point-of-care testing, which in turn has benefited the industry and is expected to increase over the forecast period.
North America is expected to dominate the global market over the forecast period due to the presence of private and government reimbursement structures for these tests. For instance, in addition to payment for generic inflammatory screening, BlueCross BlueShield of North Carolina covers C-reactive protein tests in the detection of inflamed illnesses.
Some of the major players in the market include Abbott, Aidian, Abaxis, Inc, BODITECH MED, Inc, F. Hoffmann-La Roche Ltd., Danaher, Thermo Fisher Scientific, Inc, Getein Biotech, Inc, Laboratory Corporation of America Holdings, HORIBA, Ltd., Merck KGaA, Quest Diagnostics, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Siemens Healthineers AG, Roche Ltd., and Zoetis.
The publisher has segmented the c-reactive protein testing market report on the basis of assay type, detection range, disease area, end-use, and region:
C-Reactive Protein Testing, Assay Type Outlook (Revenue-USD Million, 2017-2029)
- Immuno-turbidimetric Assay
- ELISA
- Clinical
- Non-clinical
- Chemiluminescence Immunoassay
- Others
C-Reactive Protein Testing, Detection Range Outlook (Revenue-USD Million, 2017-2029)
- hs-CRP
- Conventional CRP
- cCRP
C-Reactive Protein Testing, Disease Area Outlook (Revenue-USD Million, 2017-2029)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
C-Reactive Protein Testing, End-Use Outlook (Revenue-USD Million, 2017-2029)
- Clinics
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home Care Settings
- Others
C-Reactive Protein Testing, Regional Outlook (Revenue-USD Million, 2017-2029)
- North America
- U.S
- Canada
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Austria
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Indonesia
- Malaysia
- South Korea
- Latin America
- Brazil
- Argentina
- Mexico
- Middle East & Africa
- Israel
- Saudi Arabia
- South Africa
- UAE
Frequently Asked Questions about the C-Reactive Protein Testing Market
What is the estimated value of the C-Reactive Protein Testing Market?
The C-Reactive Protein Testing Market was estimated to be valued at $1750.27 Million in 2022.
What is the growth rate of the C-Reactive Protein Testing Market?
The growth rate of the C-Reactive Protein Testing Market is 2.9%, with an estimated value of $2158.62 Million by 2029.
What is the forecasted size of the C-Reactive Protein Testing Market?
The C-Reactive Protein Testing Market is estimated to be worth $2158.62 Million by 2029.
Who are the key companies in the C-Reactive Protein Testing Market?
Key companies in the C-Reactive Protein Testing Market include Abaxis Inc., Abbott, Aidian, BODITECH MED Inc., Danaher, F. Hoffmann, La Roche Ltd., Getein Biotech Inc., HORIBA Ltd. and Laboratory Corporation of America Holdings.
| Report Attribute | Details |
|---|---|
| No. of Pages | 128 |
| Published | January 2022 |
| Forecast Period | 2022 - 2029 |
| Estimated Market Value ( USD | $ 1750.27 Million |
| Forecasted Market Value ( USD | $ 2158.62 Million |
| Compound Annual Growth Rate | 2.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global C-reactive protein Testing Market Insights
4.1. C-reactive protein Testing - Industry Snapshot
4.2. C-reactive protein Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.2.3. Porter’s Five Forces Analysis
4.2.3.1. Bargaining Power of Suppliers (Moderate)
4.2.3.2. Threats of New Entrants: (Low)
4.2.3.3. Bargaining Power of Buyers (Moderate)
4.2.3.4. Threat of Substitute (Moderate)
4.2.3.5. Rivalry among existing firms (High)
4.2.4. PESTLE Analysis
4.2.5. C-reactive protein Testing Industry Trends
4.2.6. COVID-19 Impact Analysis
4.2. C-reactive protein Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.2.3. Porter’s Five Forces Analysis
4.2.3.1. Bargaining Power of Suppliers (Moderate)
4.2.3.2. Threats of New Entrants: (Low)
4.2.3.3. Bargaining Power of Buyers (Moderate)
4.2.3.4. Threat of Substitute (Moderate)
4.2.3.5. Rivalry among existing firms (High)
4.2.4. PESTLE Analysis
4.2.5. C-reactive protein Testing Industry Trends
4.2.6. COVID-19 Impact Analysis
5. Global C-reactive protein Testing Market, by Assay Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
5.3. Immuno-turbidimetric Assay
5.3.1. Global C-reactive protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2017 - 2029 (USD Million)
5.4. ELISA
5.4.1. Global C-reactive protein Testing Market, by ELISA, by Region, 2017 - 2029 (USD Million)
5.4.2. Clinical
5.4.2.1. Global C-reactive protein Testing Market, by Clinical, by Region, 2017 - 2029 (USD Million)
5.4.3. Non-clinical
5.4.3.1. Global C-reactive protein Testing Market, by Non-clinical, by Region, 2017 - 2029 (USD Million)
5.5. Chemiluminescence Immunoassay
5.5.1. Global C-reactive protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2017 - 2029 (USD Million)
5.6. Others
5.6.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
5.2. Introduction
5.2.1. Global C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
5.3. Immuno-turbidimetric Assay
5.3.1. Global C-reactive protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2017 - 2029 (USD Million)
5.4. ELISA
5.4.1. Global C-reactive protein Testing Market, by ELISA, by Region, 2017 - 2029 (USD Million)
5.4.2. Clinical
5.4.2.1. Global C-reactive protein Testing Market, by Clinical, by Region, 2017 - 2029 (USD Million)
5.4.3. Non-clinical
5.4.3.1. Global C-reactive protein Testing Market, by Non-clinical, by Region, 2017 - 2029 (USD Million)
5.5. Chemiluminescence Immunoassay
5.5.1. Global C-reactive protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2017 - 2029 (USD Million)
5.6. Others
5.6.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
6. Global C-reactive protein Testing Market, by Detection Range
6.1. Key Findings
6.2. Introduction
6.2.1. Global C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
6.3. hs-CRP
6.3.1. Global C-reactive protein Testing Market, by hs-CRP, by Region, 2017 - 2029 (USD Million)
6.4. Conventional CRP
6.4.1. Global C-reactive protein Testing Market, by Conventional CRP, by Region, 2017 - 2029 (USD Million)
6.5. cCRP
6.5.1. Global C-reactive protein Testing Market, by cCRP, by Region, 2017 - 2029 (USD Million)
6.2. Introduction
6.2.1. Global C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
6.3. hs-CRP
6.3.1. Global C-reactive protein Testing Market, by hs-CRP, by Region, 2017 - 2029 (USD Million)
6.4. Conventional CRP
6.4.1. Global C-reactive protein Testing Market, by Conventional CRP, by Region, 2017 - 2029 (USD Million)
6.5. cCRP
6.5.1. Global C-reactive protein Testing Market, by cCRP, by Region, 2017 - 2029 (USD Million)
7. Global C-reactive protein Testing Market, by Disease Area
7.1. Key Findings
7.2. Introduction
7.2.1. Global C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
7.3. Cardiovascular Diseases
7.3.1. Global C-reactive protein Testing Market, by Cardiovascular Diseases, By Region, 2017 - 2029 (USD Million)
7.4. Cancer
7.4.1. Global C-reactive protein Testing Market, by Cancer, By Region, 2017 - 2029 (USD Million)
7.5. Rheumatoid Arthritis
7.5.1. Global C-reactive protein Testing Market, by Rheumatoid Arthritis, By Region, 2017 - 2029 (USD Million)
7.6. Inflammatory Bowel Disease
7.6.1. Global C-reactive protein Testing Market, by Inflammatory Bowel Disease, By Region, 2017 - 2029 (USD Million)
7.7. Endometriosis
7.7.1. Global C-reactive protein Testing Market, by Endometriosis, By Region, 2017 - 2029 (USD Million)
7.8. Lupus
7.8.1. Global C-reactive protein Testing Market, by Lupus, By Region, 2017 - 2029 (USD Million)
7.2. Introduction
7.2.1. Global C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
7.3. Cardiovascular Diseases
7.3.1. Global C-reactive protein Testing Market, by Cardiovascular Diseases, By Region, 2017 - 2029 (USD Million)
7.4. Cancer
7.4.1. Global C-reactive protein Testing Market, by Cancer, By Region, 2017 - 2029 (USD Million)
7.5. Rheumatoid Arthritis
7.5.1. Global C-reactive protein Testing Market, by Rheumatoid Arthritis, By Region, 2017 - 2029 (USD Million)
7.6. Inflammatory Bowel Disease
7.6.1. Global C-reactive protein Testing Market, by Inflammatory Bowel Disease, By Region, 2017 - 2029 (USD Million)
7.7. Endometriosis
7.7.1. Global C-reactive protein Testing Market, by Endometriosis, By Region, 2017 - 2029 (USD Million)
7.8. Lupus
7.8.1. Global C-reactive protein Testing Market, by Lupus, By Region, 2017 - 2029 (USD Million)
8. Global C-reactive protein Testing Market, by End-Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
8.3. Clinics
8.3.1. Global C-reactive protein Testing Market, By Clinics, By Region, 2017 - 2029 (USD Million)
8.4. Hospitals
8.4.1. Global C-reactive protein Testing Market, by Hospitals, by Region, 2017 - 2029 (USD Million)
8.5. Laboratories
8.5.1. Global C-reactive protein Testing Market, by Laboratories, by Region, 2017 - 2029 (USD Million)
8.6. Assisted Living Healthcare Facilities
8.6.1. Global C-reactive protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2017 - 2029 (USD Million)
8.7. Home Care Settings
8.7.1. Global C-reactive protein Testing Market, by Home Care Settings, by Region, 2017 - 2029 (USD Million)
8.8. Others
8.8.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
8.2. Introduction
8.2.1. Global C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
8.3. Clinics
8.3.1. Global C-reactive protein Testing Market, By Clinics, By Region, 2017 - 2029 (USD Million)
8.4. Hospitals
8.4.1. Global C-reactive protein Testing Market, by Hospitals, by Region, 2017 - 2029 (USD Million)
8.5. Laboratories
8.5.1. Global C-reactive protein Testing Market, by Laboratories, by Region, 2017 - 2029 (USD Million)
8.6. Assisted Living Healthcare Facilities
8.6.1. Global C-reactive protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2017 - 2029 (USD Million)
8.7. Home Care Settings
8.7.1. Global C-reactive protein Testing Market, by Home Care Settings, by Region, 2017 - 2029 (USD Million)
8.8. Others
8.8.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
9. Global C-reactive protein Testing Market, by Geography
9.1. Key findings
9.2. Introduction
9.2.1. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
9.3. C-reactive protein Testing Market - North America
9.3.1. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.2. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.3. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.4. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.5. C-reactive protein Testing Market - U. S.
9.3.5.1. U. S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.5.2. U. S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.5.3. U. S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.5.4. U. S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.6. C-reactive protein Testing Market - Canada
9.3.6.1. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.6.2. Canada.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.6.3. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.6.4. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4. C-reactive protein Testing Market - Europe
9.4.1. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.2. Europe.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.3. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.4. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.5. C-reactive protein Testing Market - UK
9.4.5.1. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.5.2. UK.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.5.3. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.5.4. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.6. C-reactive protein Testing Market - France
9.4.6.1. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.6.2. France.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.6.3. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.6.4. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.7. C-reactive protein Testing Market - Germany
9.4.7.1. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.7.2. Germany.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.7.3. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.7.4. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.8. C-reactive protein Testing Market - Italy
9.4.8.1. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.8.2. Italy.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.8.3. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.8.4. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.9. C-reactive protein Testing Market - Spain
9.4.9.1. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.9.2. Spain.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.9.3. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.9.4. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.10. C-reactive protein Testing Market - Netherlands
9.4.10.1. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.10.2. Netherlands.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.10.3. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.10.4. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.11. C-reactive protein Testing Market - Austria
9.4.11.1. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.11.2. Austria.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.11.3. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.11.4. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5. C-reactive protein Testing Market - Asia Pacific
9.5.1. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.2. Asia Pacific.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.3. Asia pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.4. Asia pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.5. C-reactive protein Testing Market - China
9.5.5.1. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.5.2. China.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.5.3. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.5.4. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.6. C-reactive protein Testing Market - India
9.5.6.1. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.6.2. India.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.6.3. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.6.4. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.7. C-reactive protein Testing Market - Malaysia
9.5.7.1. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.7.2. Malaysia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.7.3. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.7.4. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.8. C-reactive protein Testing Market - Japan
9.5.8.1. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.8.2. Japan.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.8.3. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.8.4. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.9. C-reactive protein Testing Market - Indonesia
9.5.9.1. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.9.2. Indonesia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.9.3. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.9.4. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.10. C-reactive protein Testing Market - South Korea
9.5.10.1. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.10.2. South Korea.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.10.3. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.10.4. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6. C-reactive protein Testing Market - Middle East & Africa
9.6.1. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.2. Middle East & Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.3. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.4. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.5. C-reactive protein Testing Market - Saudi Arabia
9.6.5.1. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.5.2. Saudi Arabia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.5.3. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.5.4. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.6. C-reactive protein Testing Market - UAE
9.6.6.1. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.6.2. UAE.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.6.3. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.6.4. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.7. C-reactive protein Testing Market - Israel
9.6.7.1. Israel: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.7.2. Israel.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.7.3. Israel: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.7.4. Israel: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.8. C-reactive protein Testing Market - South Africa
9.6.8.1. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.8.2. South Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.8.3. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.8.4. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7. C-reactive protein Testing Market - Latin America
9.7.1. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.2. Latin America.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.3. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.4. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.5. C-reactive protein Testing Market - Mexico
9.7.5.1. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.5.2. Mexico.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.5.3. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.5.4. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.6. C-reactive protein Testing Market - Brazil
9.7.6.1. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.6.2. Brazil.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.6.3. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.6.4. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.7. C-reactive protein Testing Market - Argentina
9.7.7.1. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.7.2. Argentina.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.7.3. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.7.4. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.2. Introduction
9.2.1. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
9.3. C-reactive protein Testing Market - North America
9.3.1. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.2. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.3. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.4. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.5. C-reactive protein Testing Market - U. S.
9.3.5.1. U. S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.5.2. U. S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.5.3. U. S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.5.4. U. S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.3.6. C-reactive protein Testing Market - Canada
9.3.6.1. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.3.6.2. Canada.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.3.6.3. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.3.6.4. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4. C-reactive protein Testing Market - Europe
9.4.1. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.2. Europe.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.3. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.4. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.5. C-reactive protein Testing Market - UK
9.4.5.1. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.5.2. UK.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.5.3. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.5.4. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.6. C-reactive protein Testing Market - France
9.4.6.1. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.6.2. France.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.6.3. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.6.4. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.7. C-reactive protein Testing Market - Germany
9.4.7.1. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.7.2. Germany.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.7.3. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.7.4. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.8. C-reactive protein Testing Market - Italy
9.4.8.1. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.8.2. Italy.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.8.3. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.8.4. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.9. C-reactive protein Testing Market - Spain
9.4.9.1. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.9.2. Spain.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.9.3. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.9.4. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.10. C-reactive protein Testing Market - Netherlands
9.4.10.1. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.10.2. Netherlands.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.10.3. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.10.4. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.4.11. C-reactive protein Testing Market - Austria
9.4.11.1. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.4.11.2. Austria.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.4.11.3. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.4.11.4. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5. C-reactive protein Testing Market - Asia Pacific
9.5.1. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.2. Asia Pacific.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.3. Asia pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.4. Asia pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.5. C-reactive protein Testing Market - China
9.5.5.1. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.5.2. China.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.5.3. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.5.4. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.6. C-reactive protein Testing Market - India
9.5.6.1. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.6.2. India.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.6.3. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.6.4. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.7. C-reactive protein Testing Market - Malaysia
9.5.7.1. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.7.2. Malaysia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.7.3. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.7.4. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.8. C-reactive protein Testing Market - Japan
9.5.8.1. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.8.2. Japan.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.8.3. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.8.4. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.9. C-reactive protein Testing Market - Indonesia
9.5.9.1. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.9.2. Indonesia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.9.3. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.9.4. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.5.10. C-reactive protein Testing Market - South Korea
9.5.10.1. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.5.10.2. South Korea.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.5.10.3. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.5.10.4. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6. C-reactive protein Testing Market - Middle East & Africa
9.6.1. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.2. Middle East & Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.3. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.4. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.5. C-reactive protein Testing Market - Saudi Arabia
9.6.5.1. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.5.2. Saudi Arabia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.5.3. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.5.4. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.6. C-reactive protein Testing Market - UAE
9.6.6.1. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.6.2. UAE.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.6.3. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.6.4. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.7. C-reactive protein Testing Market - Israel
9.6.7.1. Israel: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.7.2. Israel.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.7.3. Israel: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.7.4. Israel: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.6.8. C-reactive protein Testing Market - South Africa
9.6.8.1. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.6.8.2. South Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.6.8.3. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.6.8.4. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7. C-reactive protein Testing Market - Latin America
9.7.1. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.2. Latin America.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.3. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.4. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.5. C-reactive protein Testing Market - Mexico
9.7.5.1. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.5.2. Mexico.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.5.3. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.5.4. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.6. C-reactive protein Testing Market - Brazil
9.7.6.1. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.6.2. Brazil.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.6.3. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.6.4. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
9.7.7. C-reactive protein Testing Market - Argentina
9.7.7.1. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
9.7.7.2. Argentina.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
9.7.7.3. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
9.7.7.4. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Abaxis, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Abbott
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Aidian
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. BODITECH MED, INC
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Danaher
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. F. Hoffmann-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Getein Biotech, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. HORIBA, Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Laboratory Corporation of America Holdings
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Ortho Clinical Diagnostics
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Quest Diagnostics
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Randox Laboratories Ltd.
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Roche Ltd.
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. Siemens Healthineers AG
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
11.16. Thermo Fisher Scientific, Inc.
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Benchmarking
11.16.4. Recent Development
11.17. Zoetis
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Benchmarking
11.17.4. Recent Development
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Abbott
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Aidian
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. BODITECH MED, INC
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Danaher
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. F. Hoffmann-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Getein Biotech, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. HORIBA, Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Laboratory Corporation of America Holdings
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Ortho Clinical Diagnostics
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Quest Diagnostics
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Randox Laboratories Ltd.
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Roche Ltd.
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. Siemens Healthineers AG
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
11.16. Thermo Fisher Scientific, Inc.
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Benchmarking
11.16.4. Recent Development
11.17. Zoetis
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Benchmarking
11.17.4. Recent Development
List of Tables
Table 1. Global C-reactive protein Testing Market, by Assay Type, by Region, 2017 - 2029 (USD Million)
Table 2. Global C-reactive protein Testing Market, by End-Use, by Region, 2017 - 2029 (USD Million)
Table 3. Global C-reactive protein Testing Market, by Detection Range, by Region, 2017 - 2029 (USD Million)
Table 4. Global C-reactive protein Testing Market, by Disease Area, by Region, 2017 - 2029 (USD Million)
Table 5. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Table 6. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 7. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 8. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 9. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 10. U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 11. U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 12. U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 13. U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 14. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 15. Canada: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 16. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 17. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 18. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 19. Europe: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 20. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 21. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 22. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 23. Germany: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 24. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 25. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 26. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 27. France: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 28. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 29. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 30. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 31. UK: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 32. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 33. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 34. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 35. Italy: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 36. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 37. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 38. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 39. Netherlands: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 40. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 41. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 42. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 43. Spain: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 44. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 45. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 46. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 47. Austria: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 48. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 49. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 50. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 51. Asia Pacific: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 52. Asia Pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 53. Asia Pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 54. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 55. China: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 56. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 57. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 58. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 59. Japan: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 60. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 61. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 62. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 63. India: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 64. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 65. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 66. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 67. Indonesia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 68. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 69. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 70. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 71. Malaysia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 72. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 73. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 74. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 75. South Korea: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 76. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 77. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 78. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 79. Latin America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 80. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 81. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 82. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 83. Brazil: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 84. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 85. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 86. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 87. Mexico: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 88. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 89. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 90. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 91. Argentina: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 92. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 93. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 94. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 95. Middle East & Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 96. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 97. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 98. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 99. UAE: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 100. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 101. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 102. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 103. Saudi Arabia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 104. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 105. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 106. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 107. South Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 108. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 109. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 110. Isreal: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 111. Isreal: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 112. Isreal: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 113. Isreal: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 2. Global C-reactive protein Testing Market, by End-Use, by Region, 2017 - 2029 (USD Million)
Table 3. Global C-reactive protein Testing Market, by Detection Range, by Region, 2017 - 2029 (USD Million)
Table 4. Global C-reactive protein Testing Market, by Disease Area, by Region, 2017 - 2029 (USD Million)
Table 5. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Table 6. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 7. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 8. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 9. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 10. U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 11. U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 12. U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 13. U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 14. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 15. Canada: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 16. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 17. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 18. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 19. Europe: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 20. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 21. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 22. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 23. Germany: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 24. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 25. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 26. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 27. France: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 28. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 29. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 30. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 31. UK: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 32. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 33. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 34. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 35. Italy: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 36. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 37. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 38. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 39. Netherlands: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 40. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 41. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 42. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 43. Spain: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 44. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 45. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 46. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 47. Austria: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 48. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 49. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 50. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 51. Asia Pacific: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 52. Asia Pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 53. Asia Pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 54. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 55. China: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 56. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 57. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 58. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 59. Japan: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 60. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 61. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 62. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 63. India: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 64. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 65. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 66. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 67. Indonesia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 68. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 69. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 70. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 71. Malaysia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 72. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 73. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 74. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 75. South Korea: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 76. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 77. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 78. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 79. Latin America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 80. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 81. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 82. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 83. Brazil: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 84. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 85. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 86. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 87. Mexico: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 88. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 89. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 90. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 91. Argentina: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 92. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 93. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 94. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 95. Middle East & Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 96. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 97. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 98. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 99. UAE: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 100. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 101. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 102. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 103. Saudi Arabia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 104. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 105. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 106. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 107. South Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 108. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 109. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
Table 110. Isreal: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
Table 111. Isreal: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
Table 112. Isreal: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
Table 113. Isreal: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
List of Figures
Figure 1. Global C-reactive protein Testing Market, 2017 - 2029 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Assay Type
Figure 7. Global C-reactive protein Testing Market, by Assay Type, 2020 & 2029 (USD Million)
Figure 8. Market by End-Use
Figure 9. Global C-reactive protein Testing Market, by End-Use, 2020 & 2029 (USD Million)
Figure 10. Market by Detection Range
Figure 11. Global C-reactive protein Testing Market, by Detection Range, 2020 & 2029 (USD Million)
Figure 12. Market by Disease Area
Figure 13. Global C-reactive protein Testing Market, by Disease Area, 2020 & 2029 (USD Million)
Figure 14. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Figure 15. Strategic Analysis - C-reactive protein Testing Market
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Assay Type
Figure 7. Global C-reactive protein Testing Market, by Assay Type, 2020 & 2029 (USD Million)
Figure 8. Market by End-Use
Figure 9. Global C-reactive protein Testing Market, by End-Use, 2020 & 2029 (USD Million)
Figure 10. Market by Detection Range
Figure 11. Global C-reactive protein Testing Market, by Detection Range, 2020 & 2029 (USD Million)
Figure 12. Market by Disease Area
Figure 13. Global C-reactive protein Testing Market, by Disease Area, 2020 & 2029 (USD Million)
Figure 14. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
Figure 15. Strategic Analysis - C-reactive protein Testing Market
Companies Mentioned
- Abaxis Inc.
- Abbott
- Aidian
- BODITECH MED Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Getein Biotech Inc.
- HORIBA Ltd.
- Laboratory Corporation of America Holdings
- Merck KGaA
- Ortho Clinical Diagnostics
- Quest Diagnostics
- Randox Laboratories Ltd.
- Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Zoetis.
